In murine models of carbon tetrachloride [42] and lipopolysaccharide/d-galactosamine-induced liver injury [44], and hepatic steatosis [50], CUR supplementation activated Nrf2 signaling and exerted hepatoprotective effects. The gene discussed is NFE2L2; the disease is fatty liver disease.